Palo Alto Investors LP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$412,598,000
+124.6%
4,852,383
-6.4%
22.65%
+105.3%
Q2 2020$183,685,000
+157.6%
5,182,983
-2.0%
11.03%
+84.7%
Q1 2020$71,319,000
-43.1%
5,290,746
-10.7%
5.97%
-13.5%
Q4 2019$125,335,000
+52.8%
5,923,195
-4.2%
6.90%
+26.3%
Q3 2019$82,004,000
-11.4%
6,184,320
-7.4%
5.46%
+21.3%
Q2 2019$92,607,000
-24.5%
6,676,755
+4.6%
4.50%
-12.0%
Q1 2019$122,590,000
+65.6%
6,381,555
+23.0%
5.11%
+29.8%
Q4 2018$74,008,000
-29.1%
5,186,255
+3.4%
3.94%
-6.7%
Q3 2018$104,437,000
-8.1%
5,013,764
+4.4%
4.22%
-7.1%
Q2 2018$113,696,000
+62.3%
4,803,364
+0.2%
4.54%
+51.6%
Q1 2018$70,070,000
-9.2%
4,796,008
+0.5%
3.00%
-9.8%
Q4 2017$77,152,000
+83.3%
4,774,261
+58.6%
3.32%
+87.4%
Q3 2017$42,086,000
+58.3%
3,010,4660.0%1.77%
+42.9%
Q2 2017$26,582,0003,010,4661.24%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders